Pharmaceutical Technology
April 02, 2015
Packaging Forum
39
4
Industry awaits the final revision of USP General Chapter and the impact it will have on the evaluation of sterile product package integrity.
April 02, 2015
Troubleshooting
39
4
Efficient freeze-drying processes result in time and energy savings, reduced failure rates, and improved batch consistency.
April 02, 2015
Featured Content
39
4
Quality-by-design tools improve efficiency in scale-up of pharmaceutical processes.
April 02, 2015
Featured Content
39
4
In-silico design facilitates process optimization and evaluation of process control strategies.
April 02, 2015
Product Spotlight
39
4
Meissner’s TepoFlex is a polyethylene biocontainer designed for secure handling and it is part of the One-Touch single-use systems portfolio.
April 02, 2015
Product Spotlight
39
4
Ross’ Discharge System with Electronic Pressure Control is designed for use with Ross Planetary Mixers and Multi-Shaft Mixers.
April 02, 2015
Product Spotlight
39
4
West Pharmaceutical’s sterile drug vial seal, the Flip-Off Plus, is manufactured using a production process that provides precise, consistent, and reproducible seals.
April 02, 2015
Product Spotlight
39
4
Quattroflow’s QF1200CV is a compact quaternary diaphragm pump designed for tabletop and cleanroom applications.
April 02, 2015
Industry Leaders
39
4
David Barrett, chief operating officer at cut-e, discusses The Behavioral Positioning System.
April 02, 2015
Regulatory Watch
39
4
Drug developers understand the importance of early communication with regulators, but is EMA providing enough flexibility and support to companies?
April 02, 2015
Featured Content
39
4
Emerging controlled-release technologies could lead to more effective therapies in the near future.
April 02, 2015
Peer-Reviewed Research
39
4
The Human Microbiome Project has increased our understanding of the relationship between humans and microorganisms. The authors offer a new perspective on how this knowledge should be considered in setting standards for pharmaceutical quality control in microbiology.
April 02, 2015
Featured Content
39
4
In this article, industry experts discuss critical analyses for demonstrating biosimilarity.
April 02, 2015
Featured Content
39
4
Process design experimental data and risk assessments are used to predict expected process performance and establish process performance qualification acceptance criteria.
April 02, 2015
Featured Content
39
4
New legislation and changes in policy at FDA are leading to better control of the API supply chain.
April 02, 2015
From The Editor
39
4
FDA approves a biosimilar and loses a commissioner in March.
April 02, 2015
Regulatory Watch
39
4
More reliable operations would accelerate product development and prevent drug shortages.
April 02, 2015
Global Market Report
39
4
Hope abounds for local drug discovery companies despite challenges at home.
April 02, 2015
Outsourcing Outlook
39
4
Big service providers get bigger faster thanks to Big Pharma.
April 02, 2015
39
4
Multivariate data analysis (MVDA) is being used to effectively handle complex datasets generated by process analytical technology (PAT) in biopharmaceutical process development and manufacturing.
April 02, 2015
Issue PDF
39
4
Click the title above to open the Pharmaceutical Technology April 2015 issue in an interactive PDF format.